Close
  Indian J Med Microbiol
 

Figure 26: There is significant increase in luteal estrogen in artemisinin-based combination therapy cycle compared to norma, (P = 0.001189). There is a significant luteal progesterone increase in no artemisinin-based combination therapy cycle compared to normal (P = 0.014139) (The net effect is a normal luteal function). There is a significant increase in luteal estrogen in artemisinin-based combination therapy cycle compared to no artemisinin-based combination therapy cycle (P = 0.013015). There is a significant luteal progesterone decrease in the artemisinin-based combination therapy cycle compared to the no artemisinin-based combination therapy cycle (P = 0.01484) (the net effect is a defective luteal function)

Figure 26: There is significant increase in luteal estrogen in artemisinin-based combination therapy cycle compared to norma, (<i>P</i> = 0.001189). There is a significant luteal progesterone increase in no artemisinin-based combination therapy cycle compared to normal (<i>P</i> = 0.014139) (The net effect is a normal luteal function). There is a significant increase in luteal estrogen in artemisinin-based combination therapy cycle compared to no artemisinin-based combination therapy cycle (<i>P</i> = 0.013015). There is a significant luteal progesterone decrease in the artemisinin-based combination therapy cycle compared to the no artemisinin-based combination therapy cycle (<i>P</i> = 0.01484) (the net effect is a defective luteal function)